PhD candidate Sixtine Fleury, psychological and brain sciences, led a new study identifying a brain receptor linked to psilocybin’s antidepressant and anti-anxiety benefits without triggering hallucinations. The findings point toward safer, more accessible treatments for depression and anxiety. Read more.
